title: Induction of differentiation of the human histiocytic lymphoma cell line U937 in the absence of vimentin expression.
abstract: We have studied the expression of vimentin in the human histiocytic lymphoma cell line U937, induced to differentiate along the monocyte/macrophage pathway. Normal monocytes possess a network of vimentin intermediate filaments (IFs) at all stages of maturation. The undifferentiated U937 leukemia cells contain very low amounts of vimentin, but express a conspicuous IF network when exposed to phorbol myristate acetate. In parallel, they acquire functional properties typical of cells of the monocyte lineage. These concomitant variations suggest that vimentin IFs could play a role in the process of differentiation. However, we observed that all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 confer monocyte-like properties upon U937 cells without inducing vimentin expression. We obtained increased phenotypic changes, yet in the absence of a vimentin network, by combining the effects of both inducers. These results show that vimentin expression is not crucial for the acquisition of some of the functions characteristic of the monocyte/macrophage lineage.
authors.affiliation: Laboratoire de Biologie Cellulaire, INSERM U65, Université de Montpellier II, France.
authors.forename: M
authors.initials: M
authors.lastname: Taimi
authors.forename: M T
authors.initials: MT
authors.lastname: Château
authors.forename: J
authors.initials: J
authors.lastname: Marti
authors.forename: M
authors.initials: M
authors.lastname: Pacaud
mesh_terms: D002117:Calcitriol / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005455:Fluorescent Antibody Technique; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D015151:Immunoblotting; D007382:Intermediate Filaments / Q000378:metabolism; D016403:Lymphoma, Large B-Cell, Diffuse / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D010587:Phagocytosis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014746:Vimentin / Q000235:genetics* / Q000378:metabolism / Q000502:physiology
chemical_list: D014746:Vimentin; D014212:Tretinoin; D002117:Calcitriol; D013755:Tetradecanoylphorbol Acetate